Abstract
Immunotherapy in the critically ill is an appealing notion because of the apparent abnormal immune and inflammatory responses seen in so many patients. The administration of a medication that could alter immune responses and decrease mortality in patients with sepsis could represent a 'magic bullet'. Various approaches have been tried over the last 20 yr: steroids; anti-endotoxin or anti-cytokine antibodies; cytokine receptor antagonists; and other agents with immune-modulating side-effects. However, in some respects, research along these lines has been unsuccessful or disappointing at best. The current state of knowledge is summarized with particular reference to sepsis and the acute respiratory distress syndrome.
Original language | English |
---|---|
Pages (from-to) | 70-81 |
Number of pages | 12 |
Journal | British Journal of Anaesthesia |
Volume | 103 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jul 2009 |
Bibliographical note
The authors are in receipt of research funding from the Medical Research Council, the Intensive Care Society and the British Journal of Anaesthesia.Keywords
- Cytokines
- Immune system
- Intensive care
- Respiratory distress system, adult
- Systemic inflammatory response system